Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TAXUS V: De Novo Lesion: A Randomized, Double-blind Trial to Assess TAXUS Paclitaxel-Eluting Coronary Stents, SR Formulation, in the Treatment of De Novo Coronary Lesions

NCT00301522 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00301522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00301522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TAXUS V: De Novo Lesion: A Randomized, Double-blind Trial to Assess TAXUS Paclitaxel-Eluting Coronary Stents, SR Formulation, in the Treatment of De Novo Coronary Lesions
Lead sponsor
Boston Scientific Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2003
Completion date
April 30, 2009
Enrollment
1,108 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

coronary stenosis